Clinical Trials Logo
  1. Home
  2. Primary Axillary Hyperhidrosis
  3. NCT05863104

Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis

Primary Axillary Hyperhidrosis Clinical Trial

Official title:
An Open-label, Uncontrolled, Multicenter Study to Evaluate the Safety, Local Tolerability, Systemic Exposure, and Efficacy of 1% Glycopyrronium Bromide (GPB) Cream in Adolescents With Severe Primary Axillary Hyperhidrosis

Clinical Trial Summary

The aim of this study is to evaluate the safety, tolerability and systemic exposure (in a subset of patients) of topical administration of 1% GPB in adolescents with severe primary axillary hyperhidrosis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05863104
Study type Interventional
Source Dr. August Wolff GmbH & Co. KG Arzneimittel
Contact
Status Completed
Phase Phase 2
Start date March 7, 2023
Completion date March 6, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT03627468 - A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis Phase 3
Completed NCT03658616 - Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis. Phase 3
Completed NCT02286765 - Ulthera® System for Treating Axillary Hyperhidrosis N/A
Completed NCT04599907 - Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating N/A
Completed NCT03037788 - Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis Phase 1
Terminated NCT01722461 - A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis N/A
Completed NCT02823340 - Fractionated Microneedle Radiofrequency for Treatment of Primary Axillary Hyperhidrosis N/A
Not yet recruiting NCT04159610 - Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects With Primary Axillary Hyperhidrosis Phase 2
Completed NCT01799824 - Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis Phase 2
Completed NCT03785587 - A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis Phase 2
Completed NCT03054480 - Fractional Micro-Needle Radiofrequency and I Botulinum Toxin A for Primary Axillary Hyperhidrosis N/A